2024
Impact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock
Bansal K, Gupta M, Garg M, Patel N, Truesdell A, Babar Basir M, Rab S, Ahmad T, Kapur N, Desai N, Vallabhajosyula S. Impact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock. JACC Heart Failure 2024, 12: 2087-2097. PMID: 39243243, DOI: 10.1016/j.jchf.2024.07.014.Peer-Reviewed Original ResearchPercutaneous coronary interventionCardiogenic shockAcute myocardial infarctionAnnual PCI volumesHeart failureAll-CauseHigh-volume PCI centersHigh-volume centersAMI-CSNationwide Readmissions DatabaseMedian annual PCI volumesVolume-outcome relationshipAMI-CS admissionsHospital PCI volumePercutaneous coronary intervention volumeVolume centersOrgan dysfunctionPCI centerMultivariable adjustmentHF readmissionSupportive therapyHighest quartilesQ1 hospitalsNoncardiac readmissionComorbidity burden
2023
Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention
Pettersen T, Schjott J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos H, Larsen A, Nordrehaug J, Rasmussen T, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekval T. Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention. European Heart Journal 2023, 44: ehad655.2879. DOI: 10.1093/eurheartj/ehad655.2879.Peer-Reviewed Original ResearchSelf-reported adverse drug reactionsPercutaneous coronary interventionAdverse drug reactionsPotential adverse drug reactionsPrescribed therapyCoronary interventionHospital dischargeDrug reactionsMedical recordsOdds ratioIncidence of ADRsProspective multicentre cohort studyMore adverse drug reactionsMulticentre cohort studyAcute coronary syndromeSex differencesTotal study populationConfidence intervalsPatients' medical recordsClinical drug trialsProportion of womenHeart ContinuityCoronary syndromeCohort studyPCI centerTrends in the likelihood of receiving percutaneous coronary intervention in a low-volume hospital and disparities by sociodemographic communities
Wang C, Lindquist K, Krumholz H, Hsia R. Trends in the likelihood of receiving percutaneous coronary intervention in a low-volume hospital and disparities by sociodemographic communities. PLOS ONE 2023, 18: e0279905. PMID: 36652416, PMCID: PMC9847957, DOI: 10.1371/journal.pone.0279905.Peer-Reviewed Original ResearchConceptsLow-volume hospitalsNon-Latinx WhitesRelative riskSociodemographic groupsLow-income zip codesHospital PCI volumeRetrospective cohort studyPercutaneous coronary interventionCoronary artery diseaseLow-volume centersFavorable patient outcomesLow-volume facilitiesZip code median incomeLow incomeRace/ethnicityCohort studyCoronary interventionLatinx patientsSecondary outcomesArtery diseasePCI centerPrimary outcomePCI volumeAsian patientsCertain socioeconomic factors
2022
Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions
Pettersen T, Schjott J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos H, Larsen A, Nordrehaug J, Rasmussen T, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekval T. Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions. European Heart Journal 2022, 43: ehac544.2736. DOI: 10.1093/eurheartj/ehac544.2736.Peer-Reviewed Original ResearchSelf-reported adverse drug reactionsPercutaneous coronary interventionAdverse drug reactionsPotential adverse drug reactionsHospital dischargePrescribed therapyDrug reactionsCoronary interventionMedical recordsOdds ratioIncidence of ADRsProspective multicentre cohort studyStable coronary artery diseaseMulticentre cohort studyCoronary artery diseaseConfidence intervalsPatients' medical recordsHeart ContinuityInforming PatientsMore comorbiditiesIndex hospitalizationCohort studyArtery diseasePCI centerClinical variablesPerceptions of generic medicines and medication adherence after percutaneous coronary intervention: a prospective multicentre cohort study
Pettersen TR, Schjøtt J, Allore HG, Bendz B, Borregaard B, Fridlund B, Larsen AI, Nordrehaug JE, Rotevatn S, Wentzel-Larsen T, Norekvål TM. Perceptions of generic medicines and medication adherence after percutaneous coronary intervention: a prospective multicentre cohort study. BMJ Open 2022, 12: e061689. PMID: 36127123, PMCID: PMC9490600, DOI: 10.1136/bmjopen-2022-061689.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionProspective multicentre cohort studyMulticentre cohort studyMedication adherenceCohort studyCoronary interventionFemale sexGeneric medicinesSelf-reported medication adherenceOlder ageSelf-reported health statusLow socioeconomic statusPoor mental healthLow education levelSecondary outcomesPCI centerBrand-name medicinesClinical variablesMean agePatients' perceptionsMAIN OUTCOMEHealth statusMental healthSocioeconomic statusTime pointsHealth literacy and physical and mental health status in octogenarian patients with coronary artery disease - a prospective cohort multicentre study
Instenes I, Brors G, Hjertvikrem N, Allore H, Borregaard B, Deaton C, Larsen A, Osborne R, Palm P, Thompson D, Norekval T. Health literacy and physical and mental health status in octogenarian patients with coronary artery disease - a prospective cohort multicentre study. European Journal Of Cardiovascular Nursing 2022, 21: zvac060.054. DOI: 10.1093/eurjcn/zvac060.054.Peer-Reviewed Original ResearchPercutaneous coronary interventionMental health statusGood health informationHealth Literacy QuestionnaireHealth literacyHealth statusHealth informationProspective cohort multicentre studyUnit increaseMental healthPhysical healthProspective cohort studyCoronary artery diseaseAdequate health literacyLow health literacyNumber of octogenariansSocial supportHealth-promoting behaviorsMyocardial Infarction Dimensional Assessment ScaleQuality of lifeOctogenarian patientsCohort studyCoronary interventionArtery diseasePCI center
2010
Impact of Transfer for Primary Percutaneous Coronary Intervention on Survival and Clinical Outcomes (from the HORIZONS-AMI Trial)
Wöhrle J, Desaga M, Metzger C, Huber K, Suryapranata H, Guetta V, Guagliumi G, Witzenbichler B, Parise H, Mehran R, Stone G. Impact of Transfer for Primary Percutaneous Coronary Intervention on Survival and Clinical Outcomes (from the HORIZONS-AMI Trial). The American Journal Of Cardiology 2010, 106: 1218-1224. PMID: 21029816, DOI: 10.1016/j.amjcard.2010.06.049.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, Balloon, CoronaryAnticoagulantsChi-Square DistributionCoronary AngiographyFemaleHeparinHirudinsHumansMaleMiddle AgedMyocardial InfarctionPatient TransferPeptide FragmentsProportional Hazards ModelsProspective StudiesRecombinant ProteinsStatistics, NonparametricSurvival RateTime FactorsTreatment OutcomeConceptsPrimary percutaneous coronary interventionPrimary PCIST-segment elevation myocardial infarctionHORIZONS-AMI trialPercutaneous coronary interventionClinical outcomesCoronary interventionGlycoprotein IIb/IIIa inhibitorsMajor adverse cardiac eventsNet adverse clinical eventsIIb/IIIa inhibitorsAdverse cardiac eventsAdverse clinical eventsElevation myocardial infarctionPreferred reperfusion strategyPresentation of patientsInterventional hospitalMajor bleedingReperfusion strategyBalloon timeCardiac eventsCardiac deathPCI centerUnfractionated heparinMedian time
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply